J C Reijneveld
Overview
Explore the profile of J C Reijneveld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
738
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oort Q, Reijneveld J, Sikkes S, Koekkoek J, Boele F, Young T, et al.
Eur J Cancer
. 2024 Sep;
212:114335.
PMID: 39332215
Background: Neurocognitive impairments are common in patients with a brain tumour, and may negatively impact on functioning in daily life, particularly on instrumental activities of daily living (IADL). The EORTC...
2.
Rogge A, Petersen M, Aaronson N, Conroy T, Dirven L, Fischer F, et al.
Health Qual Life Outcomes
. 2023 Nov;
21(1):124.
PMID: 37968682
Background: Cancer patients may experience a decrease in cognitive functioning before, during and after cancer treatment. So far, the Quality of Life Group of the European Organisation for Research and...
3.
Rottgering J, Varkevisser T, Gorter M, Belgers V, de Witt Hamer P, Reijneveld J, et al.
J Cancer Surviv
. 2023 Mar;
18(3):1032-1041.
PMID: 36922442
Purpose: To comprehend the complex relationship between symptoms and health-related quality of life (HRQoL) in patients with diffuse glioma, we applied symptom network analysis to identify patterns of associations between...
4.
Numan T, Kulik S, Moraal B, Reijneveld J, Stam C, de Witt Hamer P, et al.
Sci Rep
. 2021 Sep;
11(1):18990.
PMID: 34556701
Non-invasively measured brain activity is related to progression-free survival in glioma patients, suggesting its potential as a marker of glioma progression. We therefore assessed the relationship between brain activity and...
5.
Kerkhof M, Koekkoek J, Vos M, van den Bent M, Taal W, Postma T, et al.
J Neurooncol
. 2019 Feb;
142(3):463-470.
PMID: 30778733
Background: When glioma patients experience long-term seizure freedom the question arises whether antiepileptic drugs (AEDs) should be continued. As no prospective studies exist on seizure recurrence in glioma patients after...
6.
Verburg N, Hoefnagels F, Barkhof F, Boellaard R, Goldman S, Guo J, et al.
AJNR Am J Neuroradiol
. 2017 Sep;
38(10):1884-1891.
PMID: 28882867
Background: Brain imaging in diffuse glioma is used for diagnosis, treatment planning, and follow-up. Purpose: In this meta-analysis, we address the diagnostic accuracy of imaging to delineate diffuse glioma. Data...
7.
Oort Q, Dirven L, Meijer W, Sikkes S, Uitdehaag B, Reijneveld J, et al.
J Neurooncol
. 2017 Feb;
132(1):145-153.
PMID: 28150189
Both dementia and brain tumor patients exhibit cognitive decline during the course of their disease. They might therefore experience similar problems with cognitively complex daily activities (i.e., instrumental activities of...
8.
Holla F, Postma T, Blankenstein M, van Mierlo T, Vos M, Sizoo E, et al.
J Neurooncol
. 2016 Jul;
129(3):525-532.
PMID: 27401156
The S100B protein is associated with brain damage and a breached blood-brain barrier. A previous pilot study showed that high serum levels of S100B are associated with shorter survival in...
9.
Reijneveld J
Ned Tijdschr Geneeskd
. 2016 Jun;
160:D545.
PMID: 27299500
Over the last few years a considerable number of Dutch hospitals has introduced electronic patient charts. Many of these systems include an option for patients to have access to their...
10.
Nissen I, Stam C, Citroen J, Reijneveld J, Hillebrand A
Epilepsy Res
. 2016 May;
124:23-33.
PMID: 27232766
Objective: Identifying epilepsy patients for whom clinical MEG is likely to be beneficial avoids or optimizes burdensome ancillary investigations. We determined whether it could be predicted upfront if MEG would...